The Harmonized System (HS) code 30049099 pertains to "Other medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses or in forms or packings for retail sale, not elsewhere specified or included." This code is commonly used for Montelukast formulations.
United States: According to the U.S. International Trade Commission (USITC), the Most Favored Nation (MFN) tariff rate for HS code 30049099 is 0%. The U.S. does not have a Free Trade Agreement (FTA) with India that affects this tariff line. Essential medicines, including Montelukast, are generally exempt from additional duties.
Philippines: The Philippines' Tariff Commission indicates an MFN tariff rate of 0% for HS code 30049099. Under the ASEAN-India Free Trade Agreement (AIFTA), the preferential tariff rate is also 0%. Essential medicines are exempt from value-added tax (VAT) as per the Philippine Department of Finance.
Sri Lanka: The Sri Lanka Customs Department lists an MFN tariff rate of 0% for HS code 30049099. Under the South Asian Free Trade Area (SAFTA) agreement, the preferential tariff rate is 0%. Essential medicines are exempt from import duties and VAT, as per the Sri Lanka Ministry of Health.
United Kingdom: According to the UK Trade Tariff, the MFN tariff rate for HS code 30049099 is 0%. The UK does not have an FTA with India affecting this tariff line. Essential medicines are exempt from VAT, as per HM Revenue & Customs.
South Africa: The South African Revenue Service (SARS) lists an MFN tariff rate of 0% for HS code 30049099. Under the India-SACU Preferential Trade Agreement, the preferential tariff rate is 0%. Essential medicines are exempt from VAT, as per the South African Department of Health.
Uzbekistan: The State Customs Committee of Uzbekistan indicates an MFN tariff rate of 0% for HS code 30049099. Uzbekistan does not have an FTA with India affecting this tariff line. Essential medicines are exempt from import duties and VAT, as per the Uzbekistan Ministry of Health.
